Viewing nowHyundai Pregabalin Capsule 150 mg
Pregabalin 150mg
Hard capsule · Prescription medication
Hyundai Pharmaceutical Co., Ltd.

MFDS item code 201109141 · Approved 2011.10.25 · Insurance code 642003010
Treatment of neuropathic pain, treatment of fibromyalgia, adjunctive treatment of partial-onset seizures
This medication is used to relieve peripheral and central neuropathic pain in adults. It is also used as an adjunct in the treatment of partial seizures in epilepsy patients. Additionally, it is effective in improving symptoms of fibromyalgia. Through these effects, it helps manage symptoms of various neurological disorders effectively.
Administer the total daily dose of this medicine, as pregabalin, orally in 2 divided doses, regardless of food. This medicine is primarily excreted by the kidneys; therefore, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, the dose may then be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional week, the dose may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of treatment’.) 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, the dose may then be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg to 450 mg/day. The initial dose is 75 mg twice daily (150 mg/day); based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over a period of at least 1 week. 5. Patients with renal impairment This medicine is primarily excreted by the kidneys in unchanged form after passing into the systemic circulation. Since its clearance is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function ≥60, initial dose 150 mg/day, maximum dose 600 mg/day, BID or TID ≥30 -<60, initial dose 75 mg/day, maximum dose 300 mg/day, BID or TID ≥15 -<30, initial dose 25-50 mg/day, maximum dose 150 mg/day, QD or BID <15, initial dose 25 mg/day, maximum dose 75 mg/day, QD Supplemental dose after hemodialysis: 25 mg, 100 mg, single dose b TID = Total daily dose divided into 3 doses BID = Total daily dose divided into 2 doses QD = Once daily a: The total daily dose (mg/day) should be divided as specified by the dosing regimen. b: A supplemental dose refers to an additional dose given once. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (65 years of age or older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Use is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 to 17 years: Use is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or symptoms of depression occur during treatment, consult a healthcare provider immediately. Patients who are allergic to any ingredients in this medicine or have a hereditary condition of lactose intolerance should not take it. Diabetic patients should be advised to discuss treatment with their doctor, as weight gain may make blood sugar control difficult. If serious allergic reactions such as angioedema occur, stop taking the medication immediately and inform healthcare personnel. Elderly individuals may be at higher risk for falls or injuries due to dizziness or drowsiness, so they should be cautious and avoid driving or operating dangerous machinery when these symptoms occur. Blurred vision or visual changes may occur, so consult a doctor if these symptoms persist. Abruptly stopping this medication can lead to withdrawal symptoms such as insomnia, headaches, and anxiety, so physicians' guidance should be followed when tapering off the medication. Due to the risk of drug abuse, patients with a history of substance abuse should take this medication with special caution. Patients with decreased kidney function may require dose adjustments, so kidney status should be monitored during treatment. Patients with heart conditions should be cautious, as symptoms of congestive heart failure may worsen when taking this medication. Caution is needed when taking this medication with opioid analgesics due to the increased risk of central nervous system depression, leading to respiratory distress. During early pregnancy, there is a risk of fetal malformations, so women who are pregnant or planning to become pregnant should consult a doctor before taking this medication and should use effective contraception. Breastfeeding mothers should discuss with healthcare personnel about the risk of this medication passing into breast milk and its potential effects on the baby. This medication can cause dizziness and drowsiness, so it is advisable to avoid driving or operating hazardous machinery after taking it. In case of overdose, symptoms such as confusion, drowsiness, depression, and seizures may occur, and immediate emergency treatment should be sought, which may include blood dialysis if necessary. Keep out of reach of children, and do not transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best kept at room temperature between 15°C and 30°C. Proper storage will help maintain the medication's effectiveness.
A hard capsule filled with white powder that is white or light yellow.
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Hyundai Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.